Prevalence, clinical correlates, and treatment of hypertension in elderly nursing home residents

Archives of Internal Medicine

Volumn 158, Issue 21, 1998, Pages 2377-2385

  Gambassi, Giovanni ^a,b   Lapane, Kate ^b   Sgadari, Antonio ^a   Landi, Francesco ^a   Carbonin, Pierugo ^a   Hume, Anne ^c   Lipsitz, Lewis ^d   Mor, Vincent ^b   Bernabei, Roberto ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF RHODE ISLAND   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BENZOTHIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; LOOP DIURETIC AGENT; NITRATE; PHENYLALKYLAMINE; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; AGED; AGING; ARTICLE; CEREBROVASCULAR DISEASE; COGNITION; COMORBIDITY; CONGESTIVE HEART FAILURE; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEGRO; NURSING HOME; PREVALENCE; PRIORITY JOURNAL;

EID: 0032561675     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.21.2377     Document Type: Article

References (72)

1. Dannenberg AL, Garrison RJ, Kannel WB. Incidence of hypertension in the Framingham Study. Am J Public Health. 1988;78:676-679.
2. Psaty BM, Furberg CD, Kuller LH, et al. Isolated systolic hypertension and subclinical cardiovascular disease in the elderly: initial findings from the Cardiovascular Health Study. JAMA. 1992;268:1287-1291.
3. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on hypertension in the elderly. Hypertension. 1994;23:275-285.
4. Stamler J, Stamler R, Neaton J. Blood pressure, systolic and diastolic, and cardiovascular risk: US population data. Arch Intern Med. 1993;153:598-615.
5. Glynn RJ, Field TS, Rosner B, Hebert PR, Taylor JO, Hennekens CH. Evidence for a positive linear relation between blood pressure and mortality in elderly people. Lancet. 1995;345:825-829.
6. O'Donnell CJ, Ridker PM, Glynn RJ, et al. Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation. 1997;95:1132-1137.
7. Du X, Cruickshank K, McNamee R, et al. Case-control study of stroke and the quality of hypertension control in north west England. BMJ. 1997;314:272-276.
8. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and metaanalysis. JAMA. 1997;277:739-745.
9. Gueytfier F, Boutitie F, Boissel J-P, et al (The INDANA Investigators). Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men: a meta-analysis of individual patient data from randomized, controlled trials. Ann Intern Med. 1997;126:761-767.
10. Insua JT, Sacks HS, Lau T-S, et al. Drug treatment of hypertension in the elderly: a meta-analysis. Ann Intern Med. 1994;121:355-362.
11. Mulrow CD, Cornell JA, Herrera CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly: implications and generalizability of randomized trials. JAMA. 1994; 272:1932-1938.
12. Kostis JB, Davis BR, Cutler J, et al, for the SHEP Cooperative Research Group. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1997;278:212-216.
13. Staessen JA, Fagard R, Thijs L, et al. Randomised, double blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350:757-764.
14. Joint National Committee. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1993;153:154-183.
15. Joint National Committee. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2400-2448.
16. Siegel D, Lopez J. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? JAMA. 1997;278:1745-1748.
17. ManolioTA, Cutler JA, Furberg CD, Psaty BM, Whelton PK, Applegate WB. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med. 1995;155:829-837.
18. Monane M, Glynn RJ, Gurwitz JH, Bohn RL, Levin R, Avorn J. Trends in medication choices for hypertension in the elderly: the decline of thiazides. Hypertension. 1995;25:1045-1051.
19. Glynn RJ, Brock DB, Harris T, et al. Use of antihypertensive drugs and trends in blood pressure in the elderly. Arch Intern Med. 1995;155:1855-1860.
20. Furberg CD, Psaty BM, Myers JV. Nifedipine: dose-related increase in mortality in patients with coronary disease [published correction appears in Circulation. 1996;93:1475-1476]. Circulation. 1995;92:1326-1331.
21. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995;274:620-625.
22. Alderman MH, Cohen H, Roqué R, Madhavan S. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet. 1997;349:594-598.
23. Pahor M, Guralnik JM, Corti MC, Foley JD, Carbonin P, Havlik RJ. Long-term survival and use of antihypertensive medication in older persons. J Am Geriatr Soc. 1995;43:1191-1197.
24. Avorn J. Medication use and the elderly: current status and opportunities. Health Aff. Spring 1995:276-286.
25. Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA. 1992;268:1417-1422.
26. Elliott WJ. ALLHAT: the largest and most important clinical trial in hypertension ever done in the USA. Am J Hypertens. 1996;9:409-411.
27. Fried TR, Mor V. Frailty and hospitalization of long-term stay nursing home residents. J Am Geriatr Soc. 1997;45:265-269.
28. Frohlich ED. Hypertension in the elderly: only the end of the beginning. Hypertension. 1994;23:286-287.
29. Haydar ZR, Rywick T, Fleg JL. Isolated systolic hypertension in the nursing home. Nurs Home Med. 1997;5:41-49.
30. Morris JN, Hawes C, Fries BE, et al. Designing the national resident assessment instrument for nursing homes. Gerontologist. 1990;30:293-297.
31. Bernabei R, Gambassi G, Mor V. The SAGE database: introducing functional outcomes in geriatric pharmaco-epidemiology. J Am Geriatr Soc. 1998;46:251-252.
32. Bernabei R, Gambassi G, Lapane K, et al. Principal characteristics of the SAGE database: a new resource for research on outcomes in long-term care. J Gerontol. In press.
33. Gambassi G, Landi F, Peng L, et al. Validity of diagnostic and drug data in standardized nursing home resident assessments: potential for geriatric pharmacoepidemiology. Med Care. 1998;36:167-179.
34. Minimum Data Set Plus Training Manual. Natick, Mass; Eliot Press; 1991.
35. Hawes C, Morris JN, Phillips CD, Mor V, Fries BE, Nonemaker S. Reliability estimates for the Minimum Data Set for Nursing Home Resident Assessment and Care Screening (MDS). Gerontologist. 1995;2:172-178.
36. Morris JN, Fries BE, Mehr DR, et al. MDS Cognitive Performance Scale. J Gerontol. 1994;49:M174-M182.
37. Mor V, Branco K, Fleishman J, et al. The structure of social engagement among nursing home residents. J Gerontol. 1995;50:P1-P8.
38. Mantel N. Chi-square tests with one degree of freedom: extension of the Mantel-Haenszel procedure. J Am Stat Assoc. 1963;58:690-700.
39. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
40. Amery A, Birkenhager W, Brixko P, et al. Efficay of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet. 1986;2:589-592.
41. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281-1285.
42. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304:405-412.
43. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997;10: 697-704.
44. Philipp T, Anlauf M, Distler A, Holzgreve H, Michaelis J, Wellek S. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE Study. BMJ. 1997;315:154-159.
45. Stason WB, Schmid CH, Niedzwiecki D, et al. Safety of nifedipine in patients with hypertension: a meta-analysis. Hypertension. 1997;30:7-14.
46. Gong L, Zhang W, Zhu Y, et al. Shangai Trial of Nifedipine in the Elderly (STONE). J Hypertens. 1996;14:1237-1245.
47. Pogue VA, Ellis C, Michel J, Francis CK. New staging of the fifth Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC-V) alters assessment of the severity and treatment of hypertension. Hypertension. 1996;28:713-718.
48. Alderman MH, Madhavan S, Cohen H. Antihypertensive drug therapy: the effect of JNC criteria on prescribing pattern and patient status through the first year. Am J Hypertens. 1996;9:413-418.
49. Soumerai SB, McLaughlin TJ, Avorn J. Improving drug prescribing in primary care: a critical analysis of experimental literature. Milbank Q. 1989;67:268-317.
50. Wilkes MS, Doblin BH, Shapiro MF. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med. 1992;116:912-919.
51. West E, Newton J. Clinical guidelines: an ambitious national strategy [editorial]. BMJ. 1997;315:324.
52. Vogt TM, Curtis-Ireland CC, Black D, Camel G, Hughes G. Recruitment of elderly volunteers for a multicenter clinical trial: the SHEP pilot trial. Control Clin Trials. 1986;7:118-133.
53. Sudilovsky A, Croog S, Crook T, et al. Differential effects of antihypertensive medications on cognitive functioning. Psychopharmacol Bull. 1989;25:133-138.
54. Starr JM, Whalley LJ, Deary IJ. The effects of antihypertensive treatment on cognitive function: results from the HOPE Study. J Am Geriatr Soc. 1996;44: 411-415.
55. Jensen E, Dehlin O, Hagberg B, Samuelsson G, Svensson T, Lidfeldt J. Blood pressure in relation to medical, psychological and social variables in a population of 80-year-olds: survival during 6 years. J Intern Med. 1997;241:209-216.
56. Heckbert SR, Longstreth WT, Psaty BM, et al. The association of antihypertensive agents with MRI white matter findings and with modified Mini-Mental State Examination in older adults. J Am Geriatr Soc. 1997;45:1423-1433.
57. Svetkey LP, George LK, Tyroler HA, Timmons PZ, Burchett BM, Blazer DG. Effects of gender and ethnic group on blood pressure control in the elderly. Am J Hypertens. 1996;9:529-535.
58. Strulov A, Epstein L, Harth A, Tamir A. Blood pressure and hypertension in an elderly population. Eur J Epidemiol. 1990;6:160-165.
59. Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, Lyles M, for the Cardiovascular Health Study Collaborative Research Group. Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. J Clin Epidemiol. 1992;45:683-692.
60. Trenkwalder P, Ruland D, Stender M, et al. Prevalence, awareness, treatment and control of hypertension in a population over the age of 65 years: results from the Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly (STEPHY). J Hypertens. 1994;12:709-716.
61. Staessen JA, Fagard R, Thijs L, et al. Subgroup and per-protocol analysis of the Randomization European Trial on Isolated Systolic Hypertension in the Elderly. Arch Intern Med. 1998;158:1681-1691.
62. Bulpitt CJ, Fletcher AE, Amery A, et al. The Hypertension in the Very Elderly Trial (HYVET): rationale, methodology and comparison with previous trials. Drugs Aging. 1994;5:171-183.
63. Hing E, Sekscenski E, Strahan G. The National Nursing Home Survey, 1985: summary for the United States. Vital Health Stat 13. 1989;97:1-249.
64. Vaitkevicius PV, Esserwein DM, Maynard AK, O'Connor FC, Fleg JL. Frequency and importance of postprandial blood pressure reduction in elderly nursinghome patients. Ann Intern Med. 1991;15:865-870.
65. Mulrow CD, Gerety MB, Cornell JE, Lawrence VA, Kanten DN. The relationship between disease and function and perceived health in very frail elderly. J Am Geriatr Soc. 1994;42:374-380.
66. Williams B, Betley C. Inappropriate use of nonpsychotropic medications in nursing homes. J Am Geriatr Soc. 1995;43:513-519.
67. Bild DE, Fitzpatrick A, Fried LP, et al. Age-related trends in cardiovascular morbidity and physical functioning in the elderly: the Cardiovascular Health Study. J Am Geriatr Soc. 1993;41:1047-1056.
68. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the Health Examination Surveys, 1960 to 1991. Hypertension. 1995;26:60-69.
69. McGee D, Cooper R, Liao Y, Durazo-Arvizu R. Patterns of comorbidity and mortality risk in blacks and whites. Ann Epidemiol. 1996;6:381-385.
70. Haan MN, Weldon M. The influence of diabetes, hypertension, and stroke on ethnic differences in physical and cognitive functioning in an ethnically diverse older population. Ann Epidemiol. 1996;6:392-398.
71. Croft JB, Giles WH, Pollard RA, Casper ML, Anda RF, Livengood JR. National trends in the initial hospitalization for heart failure. J Am Geriatr Soc. 1997;45: 270-275.
72. Psaty BM, Savage PJ, Tell GS, et al. Temporal patterns of antihypertensive medication use among elderly patients: the Cardiovascular Health Study. JAMA. 1993; 270:1837-1841.